BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Z, Zhao Y, Li Y, Chen X. Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity. Vaccines (Basel) 2021;9:75. [PMID: 33494477 DOI: 10.3390/vaccines9020075] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Kang X, Li Y, Zhao Y, Chen X. Overcoming Aging-Associated Poor Influenza Vaccine Responses with CpG 1018 Adjuvant. Vaccines 2022;10:1894. [DOI: 10.3390/vaccines10111894] [Reference Citation Analysis]
2 Chang P, Lukosaityte D, Sealy JE, Rijal P, Sadeyen J, Bhat S, Crossley S, Daines R, Huang KA, Townsend AR, Iqbal M. Antigenic characterisation of human monoclonal antibodies for therapeutic use against H7N9 avian influenza virus.. [DOI: 10.1101/2022.09.16.508351] [Reference Citation Analysis]
3 Janssens Y, Joye J, Waerlop G, Clement F, Leroux-roels G, Leroux-roels I. The role of cell-mediated immunity against influenza and its implications for vaccine evaluation. Front Immunol 2022;13:959379. [DOI: 10.3389/fimmu.2022.959379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Barman S, Soni D, Brook B, Nanishi E, Dowling DJ. Precision Vaccine Development: Cues From Natural Immunity. Front Immunol 2021;12:662218. [PMID: 35222350 DOI: 10.3389/fimmu.2021.662218] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Li Z, Kim KH, Bhatnagar N, Park BR, Jeeva S, Jung YJ, Raha J, Kang SM, Chen X. Physical radiofrequency adjuvant enhances immune responses to influenza H5N1 vaccination. FASEB J 2022;36:e22182. [PMID: 35113455 DOI: 10.1096/fj.202101703R] [Reference Citation Analysis]
6 Weinberger B. Vaccines and Vaccination Strategies for Older Adults. Healthy Ageing and Longevity 2022. [DOI: 10.1007/978-3-030-87532-9_7] [Reference Citation Analysis]
7 Weinberger B. Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond. Immun Ageing 2021;18:38. [PMID: 34627326 DOI: 10.1186/s12979-021-00249-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]